| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.032 | 0.8 |